[1] |
孙伟,霍艳明,黄琛.慢性心力衰竭合并肾功能不全患者临床特征的回顾性研究[J].现代中医临床,2017,24(1):35-38.
|
[2] |
中华医学会心血管病学分会.中国心力衰竭诊断和治疗指南 2014[J].中华心血管病杂志,2014,42(2):98-122.
|
[3] |
Djousse L,Driver JA,Gaziano JM.Relation between modifiable lifestyle factors and lifetime risk of heart failure[J].JAMA,2009,302(4):394-400.
|
[4] |
Roger VL,Weston SA,Redifield MM,et al.Trends in heart failure incidence and survival in a community-based population[J].JAMA,2004,292(3):344-350
|
[5] |
Levy D,Kenchaiah S,Larson MG,et al.Long-term trends in the incidence of and survival with heart failure[J].N Engl J Med,2002,347(18):397-402.
|
[6] |
Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics——2013 update:a report from the American Heart Association[J].Circulation,2013,127(1):21-23.
|
[7] |
Jong P,Yusuf S,Rousseau MF,et al.Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction:a follow-up study[J].Lancet,2003,361(9372):1843-1848.
|
[8] |
Lesman-Leegte I,Jaarsma T,Coyne JC,et al.Quality of life and depressive symptoms in the elderly:acomparison between patients with heart failure and age-and gender-matched community controls[J].J Card Fail,2009,15(1):17-23.
|
[9] |
Moser DK,Yamokoski L Sun JL,et al.Improvement in healthrelated quality of life after hospitalization predicts eventfree survival in patients with advanced heart failure[J].J Card Fail,2009,15(9):763-769.
|
[10] |
Rodriguez-Artalejo F,Guallar-Castillon P,Pascual CR,et al.Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure[J].Arch Intern Med,2005,165(11):1274-1279.
|
[11] |
Majani G,Giardini A,Opasich C,et al.Effect of valsartan on quality of life when add to usual therapy for failure:results from the Valsartan Heart Failure Trial[J].J Card Fail,2005,11(4):253-259.
|
[12] |
Hunt SA,Abraham WT,Chin MH,et al.2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the Aerican College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation[J].J Am Coll Cardiol,2009,53(15):e1-e90.
|
[13] |
Yancy CW,Jessup M,Bozkurt B,et al.American College of Cardiology Foundation;American Heart Association Task Force on Practice Guidelines.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelinees[J].J Am Coll Cardiol,2013,62(16):e147-e239.
|
[14] |
Shao MJ,Wang SR,Zhao MJ,et al.The effects of velvet antler of deer on cardiac functions of rats with heart failure following myocardial infarction[J].Evid Based Complement Alternat Med,2012,24(4):7131-7149.
|
[15] |
Chen J,Yao Y,Chen H,et al.Shengmai (a traditional Chinese herbal medicine)for heart failure[J].Cochrane Database Syst Rev,2012,14(11):CD005052.
|
[16] |
Li X,Zhang J,Huang J,et al.A multicenter,randomized,double-blind,parallel-group,placebo-controlled study of the effects of qili qiangxin capsules in patients with heart failure[J].J Am Coll Cardiol,2013,62(12):1065-1072.
|
[17] |
黄正,张小玲,章超慧,等.芪苈强心胶囊治疗慢性心力衰竭对心室重构的抑制作用[J].安徽医药,2014,18(10):1961-1963.
|
[18] |
申素琴,申玉敏.芪苈强心胶囊对慢性心力衰竭患者心功能、神经内分泌及细胞因子的影响[J].河北中医,2015,37(9):1388-1390.
|
[21] |
陶玲,杜涛,缪金龙,等.芪苈强心胶囊对老年缺血性心肌病伴心力衰竭患者血浆NT-proBNP水平的影响[J].西部中医药,2015,28(8):75-77.
|
[22] |
李栋.芪苈强心胶囊联合胺碘酮治疗老年心力衰竭合并阵发性房颤疗效观察[J].西部中医药,2016,29(3):86-88.
|
[19] |
O′Gara PT,Kushner FG,Ascheim DD,et al.2013ACCF/AHA guideline for the management of ST-elevation myocardial infarction:executive summary:a report of the American College of Cardiology Foundation/American Heart Associatin Task Force on Practice Guidelines[J].Circulation,2013,82(1):529-555.
|
[20] |
Anderson J,Adams C,Antman E,et al.2012 ACCF/AHA focused update imcorporated into the ACCFAHA 2007 guidelinesforthemanagementofpatientswithunstableangina/nonst-elevation myocardial infarction[J].Circulation,2013,62(11):1040-1041.
|